Postmarket "pharmacovigilance" program on alert for adverse events from drugs

Article Abstract:

Increased reports of adverse events from commonly used drugs are causing the U.S. Food and Drug Administration (FDA) to rethink its policies and other independent "pharmacovigilance" endeavors are performing their own analyses such as the Research on Adverse Events and Reports (RADAR).

Drugs, Reports, United States. Food and Drug Administration, Adverse drug reactions

---

Study examines effects of advance access to emergency contraception

Article Abstract:

A review found that advance access to emergency contraception does not promote riskier sexual behaviors at the population level. The findings also reveal that Plan B is well-known brand of emergency contraceptive.

Usage, Complications and side effects, Contraceptives, Postcoital, Postcoital contraceptives, Plan B (Contraceptive)

---

Studies probe value of lifestyle changes for preventing type 2 diabetes

Article Abstract:

Diabetes Intervention Reaching and Educating Communities Together (DIRECT), new program seeks to educate and enlighten that a change in lifestyle may be the right way to controlling type 2 diabetes.

Evaluation, Prevention, Type 2 diabetes, Control, Life style, Lifestyles, Health education

Similar abstracts:

• Abstracts: Aspirin, "super aspirin" use in women for cardio prevention probed. Early rheumatoid arthritis treatments weighed
• Abstracts: Finding affordable housing. A review of a supervised practice programme for overseas nurses. Homes for nurses just out of reach
• Abstracts: Aspirin, "super aspirin" use in women for cardio prevention probed. part 2 Experts ponder treating prehypertension
• Abstracts: A better way for a cancer cell to die. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
• Abstracts: Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: The METEOR trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.